Dermata Therapeutics, Inc. (DRMA)
NASDAQ: DRMA · Real-Time Price · USD
1.575
+0.365 (30.17%)
Mar 20, 2026, 2:49 PM EDT - Market open
DRMA's stock price has decreased by -87.21% in the past year and price targets may not have had time to catch up.
Dermata Therapeutics Analyst Ratings
Total Analysts
1
Consensus Rating
Strong Buy
Price Target
$10.00
Upside
+534.92%
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Maxim Group | Maxim Group | Strong Buy Maintains $30 → $10 | Strong Buy | Maintains | $30 → $10 | +534.92% | Aug 21, 2025 |
| Maxim Group | Maxim Group | Strong Buy Maintains $60 → $30 | Strong Buy | Maintains | $60 → $30 | +1,804.76% | May 21, 2025 |
| Maxim Group | Maxim Group | Strong Buy Maintains $100 → $60 | Strong Buy | Maintains | $100 → $60 | +3,709.52% | Aug 21, 2024 |
| Maxim Group | Maxim Group | Strong Buy Maintains $2,400 → $600 | Strong Buy | Maintains | $2,400 → $600 | +37,995.24% | Mar 23, 2023 |
| Brookline Capital | Brookline Capital | Strong Buy Initiates $33,600 | Strong Buy | Initiates | $33,600 | +2,133,233.33% | Sep 21, 2021 |
| Maxim Group | Maxim Group | Strong Buy Initiates $21,600 | Strong Buy | Initiates | $21,600 | +1,371,328.57% | Sep 14, 2021 |